JamesLewisPoolMD

PubMed

• Clinical role of direct renin inhibition in hypertension.
  Addison A. Taylor, James L. Pool> ;American Journal of Therapeutics. 2012 May 1
• Effect of a Physician Uncertainty Reduction Intervention on Blood Pressure in Uncontrolled Hypertensives—A Cluster Randomized Trial
  David J. Hyman, Valory N. Pavlik, Anthony J. Greisinger, Wenyaw Chan, Jose Bayona, Carol L. Mansyur, Victor Simms, James L. Pool> ;Journal of General Internal Medicine. 2012 Apr 1
• Effect of angiotensin receptor blockade on insulin sensitivity and endothelial function in abdominally obese hypertensive patients with impaired fasting glucose.
  Todd S. Perlstein, Robert R. Henry, Kieren J. Mather, Michael R. Rickels, Nicola Abate, Scott M. Grundy, Yabing Mai, Jeanine B. Albu, Jennifer B. Marks, James L. Pool,...> ;Clinical Science. 2011 Aug 24
• Peripheral and central blood pressure responses of combination aliskiren/hydrochlorothiazide and amlodipine monotherapy in African American patients with stage 2 hyper...
  Keith C. Ferdinand, James L. Pool, Richard Weitzman, Das Purkayastha, Raymond R. Townsend> ;Journal of Clinical Hypertension. 2011 May 1
• AJC Editor's Consensus: Selective and Nonselective Nonsteroidal Anti-Inflammatory Drugs and Cardiovascular Risk
  Vincent E. Friedewald, Joel S. Bennett, J. Paul Christo, James L. Pool, James M. Scheiman, Lee S. Simon, Vibeke Strand, William B. White, Gary W. Williams, William C. ...> ;American Journal of Cardiology. 2010 Sep 15
• Cyclic therapy of osteoporosis with neutral phosphate and brief, high-dose pulses of etidronate.
  Lawrence E. Mallette, Adrian D. Leblanc, James L. Pool, Jeffrey I. Mechanick> ;Journal of Bone and Mineral Research. 2009 Dec 3
• Does Reducing Physician Uncertainty Improve Hypertension Control? Rationale and Methods
  Valory N. Pavlik, Anthony J. Greisinger, James L. Pool, Paul Haidet, David J. Hyman> ;Circulation-cardiovascular Quality and Outcomes. 2009 May 1
• The role of baseline blood pressure in guiding treatment choice: a secondary analysis of the use of valsartan/hydrochlorothiazide as initial therapy in hypertensive ad...
  James L. Pool, Robert Glazer, Nora Crikelair, Drew Griffin Levy> ;Clinical Drug Investigation. 2009 Jan 1
• The Editor's Roundtable: Endothelial dysfunction in cardiovascular disease.
  Vincent E. Friedewald, Thomas D. Giles, James L. Pool, Clyde W. Yancy, William C. Roberts> ;American Journal of Cardiology. 2008 Aug 15
• A double-blind, randomized study evaluating losartan potassium monotherapy or in combination with hydrochlorothiazide versus placebo in obese patients with hypertension
  Suzanne Oparil, Nicola Abate, Erluo Chen, Mark A. Creager, Vincent A. Galet, Gang Jia, Stevo Julius, A. Lerman, Paulette A. Lyle, James L. Pool, Andrew M. Tershakovec> ;Current Medical Research and Opinion. 2008 Mar 6
• Direct renin inhibition: focus on aliskiren.
  James L. Pool> ;Journal of Managed Care Pharmacy. 2007 Oct 1
• The editor's roundtable: concurrent hypertension and dyslipidemia.
  Vincent E. Friedewald, Peter H. Jones, Norman M Kaplan, James L. Pool, William C. Roberts> ;American Journal of Cardiology. 2007 Jan 1
• Aliskiren, an Orally Effective Renin Inhibitor, Provides Antihypertensive Efficacy Alone and in Combination With Valsartan
  James L. Pool, Roland E. Schmieder, Michel Azizi, Jean-Claude Aldigier, Andrzej Januszewicz, Walter Zidek, Yanntong Chiang, Andrew Satlin> ;American Journal of Hypertension. 2007 Jan 1
• Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: A double-blind, placebo-controlled study followed by long-...
  James L. Pool, Robert Glazer, Myron H. Weinberger, Roxanne Alvarado, Jie Huang, Alan Graff> ;Clinical Therapeutics. 2007 Jan 1
• Clinical pharmacology of antihypertensive therapy.
  Addison A. Taylor, James L. Pool> ;Seminars in Nephrology. 2005 Jul 1
• Is it time to move to multidrug combinations
  James L. Pool> ;American Journal of Hypertension. 2003 Nov 1
• Comparative Effects of Candesartan Cilexetil and Amlodipine in Patients With Mild Systemic Hypertension
  Robert A. Kloner, Myron Weinberger, James L. Pool, Steven G. Chrysant, Rajesh Prasad, Susan M. Harris, Teresa M. Zyczynski, Nancy Kline Leidy, Eric L. Michelson> ;American Journal of Cardiology. 2001 Mar 15
• Clinical significance of α1-adrenoceptor selectivity in the management of benign prostatic hyperplasia
  James L. Pool, Roger Kirby> ;International Urology and Nephrology. 2001 Jan 1
• Current Concepts of Pharmacotherapy in Hypertension - Alpha-Adrenergic Blocking Drugs: Evolving Role in Clinical Medicine.
  Domenic A. Sica, James L. Pool> ;Journal of Clinical Hypertension. 2000 Mar 1
• Prolonged fenoldopam infusions in patients with mild to moderate hypertension: pharmacodynamic and pharmacokinetic effects.
  Addison A. Taylor, Alexander M. M. Shepherd, William Polvino, Roberto Mangoo-Karim, Kevin D. Ballard, Sarat Sunthornyothin, Robert R. Luther, James L. Pool> ;American Journal of Hypertension. 1999 Sep 1
• Sustained hemodynamic effects of the selective dopamine-1 agonist, fenoldopam, during 48-hour infusions in hypertensive patients: a dose-tolerability study.
  Addison A. Taylor, Roberto Mangoo-Karim, Kevin D. Ballard, Robert R. Luther, James L. Pool> ;The Journal of Clinical Pharmacology. 1999 May 1
• Dose-response efficacy of valsartan, a new angiotensin II receptor blocker.
  James L. Pool, Robert Glazer, Yanntong Chiang, M Gatlin> ;Journal of Human Hypertension. 1999 Apr 1
• Dose-responsive antihypertensive efficacy of valsartan, a new angiotensin II—receptor blocker
  James L. Pool, Suzanne Oparil, Thomas Hedner, Robert Glazer, Pascale Oddou-Stock, Allen Hester> ;Clinical Therapeutics. 1998 Nov 1
• A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Trial of Four Doses of Tasosartan in Patients With Essential Hypertension
  Yves Lacourcière, James L. Pool, Laura P. Svetkey, Alan H. Gradman, Pierre Larochelle, Jacques de Champlain, William B. Smith> ;American Journal of Hypertension. 1998 Apr 1
• Dose-related antihypertensive effects of irbesartan in patients with mild-to-moderate hypertension
  James L. Pool, Robert M. Guthrie, Thomas Littlejohn, Philip Raskin, Alexander M.M. Shephard, Michael A. Weber, Matthew R. Weir, Thomas W. Wilson, James R. Wright, Kenn...> ;American Journal of Hypertension. 1998 Apr 1
• Join now to see all